Erasca Stock (NASDAQ: ERAS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.84M |
Day Range | - - - |
52 Wk Range | 1.51 - 2.97 |
Market Cap | $630.21M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 6.4% |
Days to Cover | 15.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Erasca (NASDAQ:ERAS) through any online brokerage.
Other companies in Erasca’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), PepGen (NASDAQ:PEPG), Sage Therapeutics (NASDAQ:SAGE) and AnaptysBio (NASDAQ:ANAB).
There is no analysis for Erasca.
Erasca has a consensus price target of $13.70.
The stock price for Erasca (NASDAQ: ERAS) is $2.31 last updated June 28, 2024 at 4:31 PM EDT.
There are no upcoming dividends for Erasca.
Erasca’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Erasca.
Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.